Factors associated with relapse and recurrence of major depressive disorder in patients starting mindfulness‐based cognitive therapy
J. D. de Klerk-Sluis, M. Huijbers, S. Löcke, J. Spijker, P. Spinhoven, A. Speckens, H. Ruhé
Depression and Anxiety November 9, 2021 DOI: 10.1002/da.23220 (opens in new tab) via Semantic Scholar
Summary
AI-generated from the abstractMindfulness-based cognitive therapy (MBCT) helps prevent relapse in major depressive disorder by reducing cognitive reactivity and rumination while increasing self-compassion and mindfulness. The authors note that while rumination and mindfulness after MBCT are linked to relapse, no prior research has examined whether these factors—along with cognitive reactivity and self-compassion—are associated with relapse before MBCT begins. This gap suggests that pre-treatment psychological characteristics may influence treatment outcomes, but the study does not report any new empirical data.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Medicine Psychology |
| Key finding | Argues that the association of cognitive reactivity, rumination, self-compassion, and mindfulness with relapse before initiation of MBCT has never been investigated. |
Abstract
Mindfulness‐based cognitive therapy (MBCT) is effective for relapse prevention in major depressive disorder (MDD). It reduces cognitive reactivity (CR) and rumination, and enhances self‐compassion and mindfulness. Although rumination and mindfulness after MBCT are associated with relapse, the association of CR, rumination, self‐compassion, and mindfulness with relapse before initiation of MBCT has never been investigated.